SKU : GNPX__12_28_2020_
Please be aware that we may update information relating to this company/topic at any time, and updates will be available for purchase as a new report. If you are interested in obtaining access to all of our reports and all report updates, we also have a quarterly subscriptions available. Please contact for information about our subscription plans.
Purchase 1 report for $99 or 3 reports for $249.
Genprex is a pharmaceutical development company with an innovative anti-tumor platform. Oncoprex is in Phase II clinical trials for the treatment of lung cancer. Additional indications for soft tissue cancers are likely candidates for clinical trials in the future.